MedPath

Comparison the of effects Magnesium Sulfate and triamcinolone as Adjuvants with Ropivacaine for caudal block in Low Back Pai

Phase 3
Recruiting
Conditions
Patients with low back pain who have spinal canal stenosis or several disc bulging or protrusion or degeneration changes in MRI.
low back with sciatica
M54.4
Registration Number
IRCT20230502058054N1
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

All patients with low back pain who have had canal stenosis, multiple disc herniation or multiple degenerative joint disease(based on MRI report), with at least 3 months pain and non responsive to conservative treatments such as physiotherapy with pain score of at least 4 between 30-60 years old.

Exclusion Criteria

Patients with :1-epidural steroid injection during last 3 months, without previous MRI report.2- coagulation disorders 3- pregnant 4- women with milk feeding 5- sensitivity to radiology contrast medications 5- patients with psychological disease 6- unstable hydrodynamic status. 7- previous back surgery 8- contraindication for local anesthetic drugs.9- infection 10- Allergy to medications( local anesthetic, steroid or magnesium) 11- unwillingness of patients to study 12- patients who do not sign inform consent.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of magnesium sulfate and triamcinolone as adjuvant with ropivacaine for caudal block on pain score in patients with low back pain. Timepoint: Preblock and 1 and 3 month after block. Method of measurement: numeric rating scale.
Secondary Outcome Measures
NameTimeMethod
Modified Oswestry disability questionnaire score. Timepoint: Preblock and 1 and 3 month after block. Method of measurement: Questionnaire score.
© Copyright 2025. All Rights Reserved by MedPath